These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23896958)

  • 21. Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study.
    Smeets CHW; Zuidema SU; Hulshof TA; Smalbrugge M; Gerritsen DL; Koopmans RTCM; Luijendijk HJ
    J Clin Epidemiol; 2018 Sep; 101():17-27. PubMed ID: 29782995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
    Aupperle P
    Am J Alzheimers Dis Other Demen; 2006; 21(2):101-8. PubMed ID: 16634465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.
    Ballard C; Banister C; Khan Z; Cummings J; Demos G; Coate B; Youakim JM; Owen R; Stankovic S;
    Lancet Neurol; 2018 Mar; 17(3):213-222. PubMed ID: 29452684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.
    Schneider LS; Ismail MS; Dagerman K; Davis S; Olin J; McManus D; Pfeiffer E; Ryan JM; Sultzer DL; Tariot PN
    Schizophr Bull; 2003; 29(1):57-72. PubMed ID: 12908661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of the agitation of late-life psychosis and Alzheimer's disease.
    Salzman C
    Eur Psychiatry; 2001 Jan; 16 Suppl 1():25s-28s. PubMed ID: 11520475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.
    Devanand DP; Pelton GH; Cunqueiro K; Sackeim HA; Marder K
    Int J Geriatr Psychiatry; 2011 Sep; 26(9):937-43. PubMed ID: 21845596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
    Creese B; Da Silva MV; Johar I; Ballard C
    Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antipsychotics on mortality in elderly patients with dementia: a 1-year prospective study in a nursing home.
    Suh GH; Shah A
    Int Psychogeriatr; 2005 Sep; 17(3):429-41. PubMed ID: 16252375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.
    Kamble P; Chen H; Sherer JT; Aparasu RR
    Drugs Aging; 2009; 26(6):483-92. PubMed ID: 19591523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates of agitation and depression in nursing home residents with dementia.
    Majić T; Pluta JP; Mell T; Treusch Y; Gutzmann H; Rapp MA
    Int Psychogeriatr; 2012 Nov; 24(11):1779-89. PubMed ID: 22591584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of nursing home admission and/or death in incident Alzheimer's disease and other dementia cases compared to controls: a population-based study.
    Eaker ED; Vierkant RA; Mickel SF
    J Clin Epidemiol; 2002 May; 55(5):462-8. PubMed ID: 12007549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to Carnahan.
    Lopez OL; Becker JT
    Am J Psychiatry; 2014 Feb; 171(2):227-8. PubMed ID: 24500461
    [No Abstract]   [Full Text] [Related]  

  • 35. Characteristics and psychosocial predictors of psychiatric emergency center transport and length of stay in patients with dementia and Alzheimer's disease: a preliminary report.
    Nejtek VA; Hardy S; Hall JR; Winter AS
    J Psychiatr Pract; 2011 Jul; 17(4):251-7. PubMed ID: 21775826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse risk after discontinuation of risperidone in Alzheimer's disease.
    Devanand DP; Mintzer J; Schultz SK; Andrews HF; Sultzer DL; de la Pena D; Gupta S; Colon S; Schimming C; Pelton GH; Levin B
    N Engl J Med; 2012 Oct; 367(16):1497-507. PubMed ID: 23075176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.
    Huybrechts KF; Rothman KJ; Silliman RA; Brookhart MA; Schneeweiss S
    CMAJ; 2011 Apr; 183(7):E411-9. PubMed ID: 21444611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
    De Deyn PP; Eriksson H; Svensson H;
    Int J Geriatr Psychiatry; 2012 Mar; 27(3):296-304. PubMed ID: 21538537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.
    Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R
    Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agitation and aggressiveness among the elderly population living in nursing or retirement homes in France.
    Léger JM; Moulias R; Robert P; Vellas B; Chapuy PH; Monfort JC; Khoshnood B; Bouee S; Rebah N; Gerard D
    Int Psychogeriatr; 2002 Dec; 14(4):405-16. PubMed ID: 12670061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.